SkylaWolfe Posted - 1 day ago

$ADAG $SMX LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

OpenOutcrier Posted - 5 days ago

RECAP 11/15 +Pos Comments: $ECG + Stifel $LMB + Stifel $BJ + M Science $DECK + M Science RECAP 11/15 -Neg Comments: $BLUE - BofA $ADAG - Jefferies Live Breaking trading news www.openoutcrier.com

topstockalerts Posted - 6 days ago

Top Gainers PT2 $BE $ADAG $CYD $LGCY $RCAT Details: https://topstockalerts.com/market-gainers-and-losers/

Bornjever Posted - 6 days ago

$ADAG $INO actually I have to thank u for waking me up on doing more research on MYNZ so I could see potential!!!

Bornjever Posted - 6 days ago

$ADAG $INO did the train crash on MYNZ as I was waiting last week and I finally caught Uber.

topstockalerts Posted - 6 days ago

Top Gainers PT2 $BE $ADAG $CYD $LGCY $RCAT Details: https://topstockalerts.com/market-gainers-and-losers/

Grace_Luc Posted - 1 week ago

💥 Huge news expected for MYNZ soon 💥 Nov 12: 51M volume, +28%, with 19M short volume. With everyone awaiting the meeting results, I have a strong feeling the r/s extension will be pushed out another 180 days. Mainz Biomed (MYNZ) has partnered with Thermo Fisher (TMO, $209.2B market cap, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B revenue and advanced tech will boost MYNZ’s mRNA-based assays, achieving 85% detection for advanced adenomas, compared to competitors' 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Sentiment: Positive 1. Strategic partnership with industry giant Thermo Fisher 2. Access to Thermo Fisher's advanced tech 3. Potential for global commercialization 4. Development of home collection screening capability Win-win as TMO steps into the CRC market, too. Calling all apes, let’s crush the short sellers—this bull run is ours. $ADAG $SMX

_www_larval_com_ Posted - 2 weeks ago

$ADAG has turned 7% higher to 0% (~108Kv) moments ago, follow for more volatility.

PenkeTrading Posted - 10/29/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Adagene Inc. Is that bullish or bearish? $ADAG #Adagene #RsiOverbought #NASDAQ

RollingDollars Posted - 10/29/24

$ADAG

RollingDollars Posted - 10/25/24

$ADAG

RollingDollars Posted - 10/24/24

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

RollingDollars Posted - 1 month ago

$ADAG

JimMacmara Posted - 09/25/24

$ADAG only a moron would need help..here, low iq -er Dow hits a record high again ..and ADAP , is sucking wind…does it need Dow 50,000 to get some legs …the POS !!!

Stmkr Posted - 2 months ago

$ADAG AEs similar to pembro monotherapy.

Stmkr Posted - 2 months ago

$ADAG

Scooter0732 Posted - 2 months ago

$ADAG overpromise underdeliver.

_www_larval_com_ Posted - 2 months ago

$ADAG has sunk -11% lower to -9% (~218Kv) in the last few minutes, follow for more volatility.

Stmkr Posted - 2 months ago

$ADAG What I like about the data; - Great safety (= room to increase dose) - Decent (but not great yet) efficacy in patients with otherwise dismal prognosis - I think the potentlial of the 20mg/kg loading is underestimated. Based on pk/pd data target concentrations are reached much earlier, which could make a huge difference for these patients who progress very quickly. Initial data expected later this year from from this cohort. What I don't like; -Efficacy only in the subgroup without either peritoneal or liver meta. - No responses at 10mg/kg q6w but similar OS vs q3w, which is strange. - Company insists that q6w dosing could still be used as a starting dose (which doesnt make sense based on these data, eps pk/pd data). But I agree it could be used as a step down to reduce toxicity.

Scooter0732 Posted - 2 months ago

$ADAG Look carefully at the spider plot there's a PR that crosses 30% but then crosses back and they count that as a PR, eliminate that and the ORR data goes down further to 17.6%. I don't think that one would be counted as a PR under RECIST. They also breakdown the efficacy by a subpopulation NLPM which is a further breakdown from NLM. In short, there's a little bit of data manipulation going on here. Typical bioturd stuff. My overall impression is the data suggests ADG126 is as good as Agen1181 if things surprise on the upside in later studies and is possibly quite a bit worse.

Scooter0732 Posted - 2 months ago

$ADAG I think the market was already worried that they needed 20mg as a loading dose. This change in strategy from Q3W or Q6W suggested a problem with the data. The fact that they are pursuing this now reinforces the message. I get the drop.

_www_larval_com_ Posted - 2 months ago

$GLMD -10%[297%] $SWVL -8%[-43%] $ADAG -8%[-25%] $RLMD -7%[8%] $HCWC 6%[-19%] most notable movement into the final minutes of trading.

Scooter0732 Posted - 2 months ago

$ADAG Spider plots don't look particularly exciting a lot of PD trending there.

Scooter0732 Posted - 2 months ago

$ADAG Crazy data was good!

Stmkr Posted - 2 months ago

$ADAG Rebound from here?